Marine Drugs (Jun 2014)

Acetylcholinesterase Inhibitory Activity of Pigment Echinochrome A from Sea Urchin Scaphechinus mirabilis

  • Sung Ryul Lee,
  • Julius Ryan D. Pronto,
  • Bolor-Erdene Sarankhuu,
  • Kyung Soo Ko,
  • Byoung Doo Rhee,
  • Nari Kim,
  • Natalia P. Mishchenko,
  • Sergey A. Fedoreyev,
  • Valentin A. Stonik,
  • Jin Han

DOI
https://doi.org/10.3390/md12063560
Journal volume & issue
Vol. 12, no. 6
pp. 3560 – 3573

Abstract

Read online

Echinochrome A (EchA) is a dark-red pigment of the polyhydroxynaphthoquinone class isolated from sea urchin Scaphechinus mirabilis. Acetylcholinesterase (AChE) inhibitors are used in the treatment of various neuromuscular disorders, and are considered as strong therapeutic agents for the treatment of Alzheimer’s disease (AD). Although EchA is clinically used to treat ophthalmic diseases and limit infarct formation during ischemia/ reperfusion injury, anti-AChE effect of EchA is still unknown. In this study, we investigated the anti-AChE effect of EchA in vitro. EchA and its exhausted form which lost anti-oxidant capacity did not show any significant cytotoxicy on the H9c2 and A7r5 cells. EchA inhibited AChE with an irreversible and uncompetitive mode. In addition, EchA showed reactive oxygen species scavenging activity, particularly with nitric oxide. These findings indicate new therapeutic potential for EchA in treating reduced acetylcholine-related diseases including AD and provide an insight into developing new AChE inhibitors.

Keywords